WCG Wealth Advisors LLC purchased a new position in Docusign Inc. (NASDAQ:DOCU - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 10,020 shares of the company's stock, valued at approximately $816,000.
Other hedge funds have also recently modified their holdings of the company. Hemington Wealth Management lifted its position in shares of Docusign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock worth $28,000 after purchasing an additional 264 shares during the period. Golden State Wealth Management LLC lifted its position in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after purchasing an additional 322 shares during the period. Summit Securities Group LLC purchased a new stake in shares of Docusign in the 1st quarter worth approximately $34,000. Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign in the 4th quarter worth approximately $37,000. Finally, MassMutual Private Wealth & Trust FSB lifted its position in shares of Docusign by 153.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 453 shares of the company's stock worth $37,000 after purchasing an additional 274 shares during the period. Hedge funds and other institutional investors own 77.64% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on DOCU. Wedbush lowered their price target on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a research report on Thursday, June 12th. JPMorgan Chase & Co. decreased their target price on shares of Docusign from $81.00 to $77.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Robert W. Baird decreased their target price on shares of Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Bank of America decreased their target price on shares of Docusign from $88.00 to $85.00 and set a "neutral" rating for the company in a research report on Friday, June 6th. Finally, Citigroup decreased their target price on shares of Docusign from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, June 9th. Four equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. According to MarketBeat, Docusign currently has a consensus rating of "Hold" and an average price target of $89.77.
Get Our Latest Research Report on DOCU
Docusign Trading Up 1.5%
Shares of NASDAQ DOCU traded up $1.15 during midday trading on Friday, reaching $76.66. The company had a trading volume of 2,272,539 shares, compared to its average volume of 2,302,764. The business's 50-day simple moving average is $75.41 and its 200 day simple moving average is $79.73. The stock has a market cap of $15.49 billion, a P/E ratio of 14.49, a P/E/G ratio of 28.61 and a beta of 1.01. Docusign Inc. has a 1 year low of $54.31 and a 1 year high of $107.86.
Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.09. The business had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. Docusign had a net margin of 36.50% and a return on equity of 14.27%. The business's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the company posted $0.82 earnings per share. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Docusign Inc. will post 1.17 earnings per share for the current year.
Docusign announced that its board has approved a stock buyback plan on Thursday, June 5th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 6.6% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board believes its shares are undervalued.
Insider Buying and Selling at Docusign
In other news, insider Robert Chatwani sold 22,875 shares of the stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the sale, the insider owned 72,126 shares in the company, valued at $5,394,303.54. This represents a 24.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Allan C. Thygesen sold 40,000 shares of the firm's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the sale, the chief executive officer owned 143,983 shares in the company, valued at approximately $11,160,122.33. This represents a 21.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 78,552 shares of company stock worth $5,983,631 over the last ninety days. 1.01% of the stock is owned by insiders.
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.